文献速递头颈部肿瘤放疗

基于动态风险适应方法构建鼻咽癌个体化监测框架

Constructing an individualized surveillance framework for nasopharyngeal carcinoma based on a dynamic risk-adapted approach.
PubMed 文献 · Radiother Oncol · 2023-05-18

本研究纳入2005年6月至2011年12月接受根治性化疗的非转移性鼻咽癌患者1616例,采用Kaplan-Meier法计算条件生存率,评估根治性放化疗后动态生存与复发风险,并据此提出不同临床分期的个体化随访策略。

要点

  • 随生存时间延长,条件性无局部区域复发生存率与无远处转移生存率逐渐升高。
  • I-II期年度局部区域复发风险始终低于2%;III-IVa期前三年高于2%,第三年后降至2%以下。
  • I期年度远处转移风险始终低于2%;II期前三年为2.5-3.8%;III-IVa期持续高于5%,第三年后降至5%以下。

核心结论

  • 局部区域复发与远处转移的年度风险随时间推移而下降。
  • 基于生存概率随时间动态变化建立的个体化监测模型可为优化临床决策提供关键预后信息,并有助于制定监测咨询和资源分配。

研究设计与样本

  • 纳入2005年6月至2011年12月期间接受根治性化疗的非转移性鼻咽癌患者,共1616例。
  • 采用Kaplan-Meier法计算条件生存率。

主要发现

  • 随生存时间延长,条件性无局部区域复发生存率与无远处转移生存率均逐渐升高。
  • 年度复发风险随时间的变化模式在不同临床分期之间存在差异。
  • I-II期年度局部区域复发风险始终低于2%;III-IVa期前三年高于2%,第三年后降至2%以下。
  • I期年度远处转移风险始终低于2%;II期前三年为2.5-3.8%;III-IVa期持续高于5%,第三年后降至5%以下。

关键数值与推荐

  • I-II期年度局部区域复发风险始终低于2%。
  • III-IVa期年度局部区域复发风险前三年高于2%,第三年后降至2%以下。
  • I期年度远处转移风险始终低于2%。
  • II期年度远处转移风险前三年为2.5-3.8%。
  • III-IVa期年度远处转移风险持续高于5%,第三年后降至5%以下。

临床怎么用

  • 基于生存概率随时间的动态变化,针对不同临床分期建立了不同随访强度和频率的监测计划。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: This study aims to evaluate the dynamic survival and recurrence hazard of nasopharyngeal carcinoma(NPC) patients after definitive chemoradiotherapy utilizing conditional survival(CS) analysis, and to propose a personalized surveillance strategy at different clinical stages. MATERIALS AND METHODS: Non-metastatic NPC patients who received curative chemotherapy between June 2005 and December 2011 were included. The Kaplan-Meier method was used to calculate the CS rate. RESULTS: A total of 1616 patients were analyzed. With the prolongation of survival time, both conditional locoregional recurrence free survival and distant metastatic free survival increased gradually. Changing pattern of annual recurrence risk over time varied among different clinical stages. The annual locoregional recurrence(LRR) risk in stage I-II was always less than 2%, while in stage III-IVa, it was greater than 2% for the first three years and decreased to below 2% only after the third year. The annual distant metastases (DM) risk was always less than 2% in stage I, but higher than 2% in stage II for the first 3 years (2.5-3.8%). For those with stage III-IVa, the annual DM risk retained at a high level(>5%), and only decreased to < 5% after the third year. Based on the dynamic changes in survival probability over time, we established a surveillance plan with different follow-up intensities and frequencies for different clinical stages. CONCLUSION: The annual risk of LRR and DM decrease over time. Our individual surveillance model will provide critical prognostic information to optimize clinical decision-making, and promote to formulate surveillance counseling and help with resources allocation.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Lu T, Xu H, Huang W, et al. Constructing an individualized surveillance framework for nasopharyngeal carcinoma based on a dynamic risk-adapted approach. Radiother Oncol. 2023. PMID: 37207875. doi:10.1016/j.radonc.2023.109716

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。